Organic Letters
Letter
(6) Other studies involving secondary alkylzinc reagents: (a) Thaler,
T.; Haag, B.; Gavryushin, A.; Schober, K.; Hartmann, E.; Gschwind, R.
M.; Zipse, H.; Knochel, P. Nat. Chem. 2010, 2, 125. (b) Krasovskiy, A.;
Duplais, C.; Lipshutz, B. H. J. Am. Chem. Soc. 2009, 131, 15592.
(7) Boron-based secondary alkyl nucleophile: (a) Dreher, S. D.;
Dormer, P. G.; Sandrock, D. L.; Molander, G. A. J. Am. Chem. Soc.
2008, 130, 9257. (b) van den Hoogenband, A.; Lange, J. H. M.;
Terpstra, J. W.; Koch, M.; Visser, G. M.; Visser, M.; Korstanje, T. J.;
Jastrzebski, J. T. B. H. Tetrahedron Lett. 2008, 49, 4122.
(8) Tin-based secondary alkyl nucleophile: Li, L.; Wang, C.-Y.;
Huang, R.; Biscoe, M. R. Nat. Chem. 2013, 5, 607.
(9) (a) Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew.
Chem., Int. Ed. 2005, 44, 1371. (b) Su, M.; Buchwald, S. L. Angew.
Chem., Int. Ed. 2012, 51, 4710.
(10) (a) Joule, J. A.; Mills, K. Heterocyclic Chemistry, 5th ed.; Wiley:
Chichester, 2010. (b) Leurs, R.; Bakker, R. A.; Timmerman, H.; de
Esch, I. J. P. Nat. Rev. Drug Discovery 2005, 4, 107.
substituents and the biaryl backbone is critical to the success of
selective coupling of secondary alkyl nucleophiles.
In summary, we have developed general catalyst systems
allowing for the highly selective cross-coupling of secondary
alkylzinc reagents and heteroaryl halides under mild conditions.
Our protocol is effective with a broad spectrum of heteroaryl
halides, delivering an array of complex heterocycles possessing
secondary alkyl substituents that are frequently found in
biologically active compounds. Furthermore, design and
evaluation of a series of biarylphosphine ligands bearing a
2,6-bis(dimethylamino)phenyl group proximal to the phos-
phine have led to a new catalyst that demonstrated superior
selectivity for the coupling of electron-deficient heteroaryl
halides. Application of these newly developed catalysts in cross-
coupling reactions where transmetalation or reductive elimi-
nation remains challenging is topic of onging investigation in
our laboratory.
(11) Krasovskiy, A.; Malakhov, V.; Gavryushin, A.; Knochel, P.
Angew. Chem., Int. Ed. 2006, 45, 6040.
(12) (a) Bruno, N. C.; Tudge, M. T.; Buchwald, S. L. Chem. Sci.
2013, 4, 916. (b) Yang, Y.; Oldenhuis, N. J.; Buchwald, S. L. Angew.
Chem., Int. Ed. 2013, 52, 615. (c) Yang, Y.; Mustard, T. J. L.; Cheong,
P. H.-Y. Angew. Chem., Int. Ed. 2013, 52, 14098.
(13) CPhos (CAS no. 1160556-64-8) is now commercially available
from Aldrich (catalog no. 759171).
(14) For the effect of added LiCl, see: McCann, L. C.; Hunter, H. N.;
Clyburne, J. A. C.; Organ, M. G. Angew. Chem., Int. Ed. 2012, 51, 7024.
(15) For reviews on mechanistic aspects of reductive elimination, see:
(a) Hartwig, J. F. Organotransition Metal Chemistry: from Bonding to
Catalysis; University Science Books: Sausalito, 2009. (b) Hartwig, J. F.
Inorg. Chem. 2007, 46, 1936.
(16) Significant differences between Et- and Cy-substituents are
evident by comparing Tolman’s electronic parameters for PEt3 and
PCy3, showing that Et- is less electron-donating than Cy-: PEt3, 2061.7
cm−1; PCy3, 2056.4 cm−1. For a review, see: Tolman, C. A. Chem. Rev.
1977, 77, 313.
ASSOCIATED CONTENT
* Supporting Information
Experimental procedures, characterization, and spectral data.
This material is available free of charge via the Internet at
■
S
AUTHOR INFORMATION
■
Corresponding Author
Notes
The authors declare the following competing financial
interest(s): MIT has patents on some of the ligands and
precatalysts described in this work from which S.L.B. as well as
former or current co-workers receive royalty payments.
ACKNOWLEDGMENTS
■
Financial support is provided by National Institutes of Health
(Grant No. GM46059). K.N. thanks the Swiss National Science
Foundation for a postdoctoral fellowship. We thank Dr. Peter
Muller (MIT) for X-ray crystal structure solution and Dr. Tom
̈
Kinzel (MIT) for preliminary mechanistic studies. The content
is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institute
of Health.
REFERENCES
■
(1) Two of the ten top selling drugs estimated by US retail sales
(Lipitor and Crestor) contain a secondary alkyl substituent on the
heterocyclic core. See: Mack, D. J.; Weinrich, M. L.; Vitaku, E.;
(2) (a) de Meijere, A.; Diederich, F. Metal-Catalyzed Cross-Coupling
Reactions, 2nd ed.; Wiley-VCH: Weinheim, 2004. (b) Negishi, E.-i.
Handbook of Organopalladium Chemistry for Organic Synthesis; Wiley-
Interscience: New York, 2002.
(3) (a) Tamao, K.; Kiso, Y.; Sumitani, K.; Kumada, M. J. Am. Chem.
Soc. 1972, 94, 9268. (b) Hayashi, T.; Konishi, M.; Kobori, Y.; Kumada,
M.; Higuchi, T.; Hirotsy, K. J. Am. Chem. Soc. 1984, 106, 158.
(4) Han, C.; Buchwald, S. L. J. Am. Chem. Soc. 2009, 131, 7532−
7533.
(5) (a) Pompeo, M.; Froese, R. D. J.; Hadei, N.; Organ, M. G. Angew.
Chem., Int. Ed. 2012, 51, 11354. (b) C
Commun. 2011, 47, 5181. (c) Recent review on Pd-PEPPSI
precatalysts: Valente, C.; Calimsiz, S.; Hoi, K. H.; Mallik, D.; Sayah,
M.; Organ, M. G. Angew. Chem., Int. Ed. 2012, 51, 3314.
̧alimsiz, S.; Organ, M. G. Chem.
̧
D
dx.doi.org/10.1021/ol502230p | Org. Lett. XXXX, XXX, XXX−XXX